Double binding sites on tumor target may provide future combination therapy

[News]

Researchers from the University of Pennsylvania School of Medicine and colleagues at Merck Serono Research in Germany have found that two drugs bind to receptor sites on some tumors in different places at the same time, suggesting the possibility of a new combination therapy for certain types of cancer.

More... (http://www.news-medical.net/?id=37145)